This page includes the latest FDA filings for Foundation Medicine Inc 150 Second Street 1st Floorcambridge Ma 02141 Pma Numberp170019 Supplement Numbers034 Date Received03 18 2022 Decision Date04 13 2022 Product Code Pqp Advisory Committee Pathology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Foundation Medicine, Inc.150 Second Street, 1st Floorcambridge, MA 02141 PMA NumberP170019 Supplement NumberS034 Date Received03/18/2022 Decision Date04/13/2022 Product Code PQP Advisory Committee Pathology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No | FoundationOne CDx (FICDx) | 2022-04-13 |